A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a “game changer” in the fight against the virus had a significantly higher risk of death compared with those who did not.
Trending:
Hydroxychloroquine, antimalarial drug touted by President Trump, is linked to increased risk of death in coronavirus patients, study says